Memantine is an FDA-approved medication that can be added to Alzheimer's treatment to slow cognitive decline and help with daily functioning in people with moderate to severe disease. Your family should understand how it works, whether it's the right choice for your loved one, and what questions will help your prescriber decide if it fits your situation. Memantine belongs to a different drug class than the cholinesterase inhibitors (like donepezil) often given earlier in Alzheimer's, and it can be used alone or combined with them. The decision to add memantine depends on disease stage, current medications, kidney function, and your family's goals for care.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How Memantine Works and What It Can Do
- Dosing, Titration, and Timeline
- Side Effects and Drug Interactions You Need to Know
- Cost, Coverage, and Affordability
- What Questions to Ask Your Prescriber
- When Memantine May Not Be the Right Choice
- Frequently Asked Questions
How Memantine Works and What It Can Do
Memantine blocks N-methyl-D-aspartate (NMDA) receptors in the brain, but only when they are overactive—a key design that lets normal brain signaling continue while protecting against damage from excessive glutamate. This mechanism is different from older NMDA blockers that indiscriminately shut down these receptors.
A meta-analysis of 18 randomized trials found memantine produces small improvements in cognition but shows stronger benefits for activities of daily living such as toileting and grooming. When combined with donepezil, the benefit is larger, especially in people with severe impairment. However, the improvement is modest—families should expect slowing of decline rather than restoration of lost abilities.
Dosing, Titration, and Timeline
Memantine starts at 5 mg daily and increases by 5 mg weekly to reach 20 mg daily (10 mg twice daily) over four weeks. This gradual titration reduces the chance of dizziness and confusion early on. People on dialysis or with severe kidney disease receive lower maintenance doses, so your prescriber will adjust based on kidney function.
Benefits are not immediate. Families often see changes in cognition or function over weeks to months, not days. If your loved one experiences persistent dizziness or confusion during titration, ask whether a slower increase is possible or whether memantine is right for them.
Side Effects and Drug Interactions You Need to Know
Common side effects include dizziness, headache, confusion, and constipation. Fewer patients discontinue memantine (7.4%) due to side effects than stop placebo (12.4%), suggesting most people tolerate it reasonably well. Serious events like seizures or Stevens-Johnson syndrome are rare but documented. Memantine significantly interacts with cimetidine (a heartburn medicine that increases memantine levels threefold), amantadine, dextromethorphan (a cough suppressant), and drugs that alkalinize urine such as acetazolamide. Before starting, give your prescriber a complete list of all over-the-counter and prescription medications, including cold remedies and supplements.
Cost, Coverage, and Affordability
Generic memantine costs approximately $5.40 for a 30-day supply, making it affordable for most families. The branded combination form Namzaric™ (memantine plus donepezil) costs around $405 monthly. Medicare Part D covers memantine, though your plan may require prior approval or step therapy (proving other treatments did not work first).
Check your specific plan's formulary and call your insurance before filling a prescription. Some plans cover generic memantine without restriction while requiring prior approval for the combination form. This detail can save hundreds of dollars monthly.
What Questions to Ask Your Prescriber
Before your loved one starts memantine, ask these practical questions:.
- Is moderate to severe Alzheimer's the confirmed diagnosis, and does cognitive imaging rule out other causes?
- What specific improvement are we hoping for—cognition, daily functioning, behavior, or slowing decline?
- Are there any drug interactions with current medications, and will you check kidney function before starting?
- What timeline should I expect to see changes, and how will we measure whether it's working?
- What symptoms during titration warrant calling you, and can we adjust the pace if side effects emerge?
When Memantine May Not Be the Right Choice
Although memantine improves behavioral symptoms in combination therapy, it did not significantly reduce severe agitation when tested as a primary goal in moderate-to-severe disease. If agitation is the primary concern driving the decision to treat, ask your prescriber whether other approaches—behavioral interventions, environmental changes, or other medications—might be more effective for that specific problem.
Memantine is not recommended for mild cognitive impairment or early-stage Alzheimer's unless your prescriber has a specific reason. It is also not a treatment for vascular dementia, Lewy body dementia, or frontotemporal dementia, despite sometimes being prescribed off-label for those conditions.
Frequently Asked Questions
Can memantine be started without other Alzheimer's medications?
Yes. Memantine can be used alone, though research shows stronger benefits when combined with donepezil. Your prescriber will recommend based on disease stage and what your loved one has already tried.
How long should my family wait before deciding whether memantine is working?
Changes often take weeks to months to become apparent. Discuss with your prescriber a timeline and specific signs you'll look for—such as fewer repeat questions, steadier mood, or less assistance needed for dressing—rather than expecting dramatic improvement.
What happens if memantine is discontinued?
Cognitive decline typically resumes at the previous pace. Stopping abruptly does not cause rebound symptoms, but ask your prescriber before stopping, as the decision depends on current function and other treatments in place.
